News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,633 Results
Type
Article (434)
Company Profile (1)
Press Release (13198)
Section
Business (4465)
Career Advice (3)
Deals (2678)
Drug Development (1472)
Employer Resources (2)
FDA (232)
Job Trends (272)
News (8416)
Policy (425)
Tag
Academia (31)
Allergies (1)
Alliances (1415)
Alzheimer's disease (7)
Antibody-drug conjugate (ADC) (22)
Approvals (239)
Artificial intelligence (14)
Autoimmune disease (3)
Automation (1)
Bankruptcy (7)
Best Places to Work (216)
Brain cancer (4)
Breast cancer (25)
Cancer (158)
Cardiovascular disease (14)
Career advice (3)
CAR-T (6)
CDC (1)
Cell therapy (13)
Clinical research (1165)
Collaboration (75)
Compensation (1)
COVID-19 (13)
CRISPR (2)
C-suite (11)
Cystic fibrosis (2)
Data (158)
Depression (5)
Diabetes (11)
Diagnostics (172)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (15)
Duchenne muscular dystrophy (2)
Earnings (2380)
Editorial (1)
Employer resources (2)
Events (1535)
Executive appointments (18)
FDA (305)
Funding (24)
Gene editing (3)
Generative AI (1)
Gene therapy (11)
GLP-1 (17)
Government (25)
Grass and pollen (1)
Guidances (35)
Healthcare (400)
Immunology and inflammation (4)
Infectious disease (14)
Inflammatory bowel disease (1)
Influenza (1)
Intellectual property (5)
IPO (581)
Job creations (65)
Job search strategy (2)
JPM (1)
Kidney cancer (1)
Layoffs (12)
Legal (98)
Liver cancer (3)
Lung cancer (20)
Lymphoma (5)
Manufacturing (25)
MASH (5)
Medical device (349)
Medtech (351)
Mergers & acquisitions (2263)
Metabolic disorders (20)
NASH (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (2)
Neuroscience (28)
NextGen: Class of 2026 (136)
Non-profit (33)
Obesity (7)
Opinion (6)
Ovarian cancer (2)
Pain (9)
Pancreatic cancer (10)
Parkinson's disease (3)
Patents (13)
Patient recruitment (5)
People (691)
Pharmaceutical (1)
Phase 1 (451)
Phase 2 (580)
Phase 3 (290)
Pipeline (129)
Postmarket research (29)
Preclinical (281)
Press Release (1)
Prostate cancer (8)
Radiopharmaceuticals (10)
Rare diseases (18)
Real estate (114)
Recruiting (1)
Regulatory (358)
Research institute (34)
Resumes & cover letters (1)
RNA editing (1)
Schizophrenia (8)
Series A (6)
Series B (3)
Sickle cell disease (3)
Sponsored (2)
Startups (83)
Supply chain (3)
Tariffs (1)
The Weekly (1)
Vaccines (8)
Venture capital (2)
Weight loss (8)
Date
Last 7 days (14)
Last 30 days (58)
Last 365 days (798)
2026 (76)
2025 (810)
2024 (813)
2023 (923)
2022 (1070)
2021 (1197)
2020 (1228)
2019 (1093)
2018 (821)
2017 (692)
2016 (535)
2015 (774)
2014 (514)
2013 (361)
2012 (391)
2011 (377)
2010 (335)
Location
Africa (12)
Asia (981)
Australia (169)
California (301)
Canada (114)
China (48)
Colorado (7)
Connecticut (5)
Delaware (5)
Europe (2463)
Florida (37)
Georgia (4)
Idaho (2)
Illinois (12)
India (1)
Indiana (10)
Japan (10)
Louisiana (2)
Maryland (19)
Massachusetts (186)
Michigan (1)
Minnesota (21)
Missouri (1)
New Hampshire (1)
New Jersey (43)
New Mexico (1)
New York (76)
North Carolina (25)
North Dakota (1)
Northern California (142)
Ohio (23)
Pennsylvania (74)
Rhode Island (2)
South America (40)
Southern California (144)
Tennessee (46)
Texas (36)
United States (944)
Utah (8)
Washington D.C. (1)
Washington State (18)
Wisconsin (5)
Wyoming (1)
13,633 Results for "synergy pharmaceuticals.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Skye’s CB1 Inhibitor Shows ‘Intriguing Synergy’ With Wegovy, Despite Mid-Stage Obesity Fail
Skye Bioscience’s nimacimab fell short of investor and company expectations, but showed encouraging weight-loss results when combined with Wegovy, according to analysts at William Blair.
October 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
December 8, 2025
·
7 min read
Press Releases
First Patient Dosed in SYNERGY-101, a Global, Randomized Phase 2 Clinical Trial of STK-012 in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
November 14, 2025
·
3 min read
BioForest
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
Pattern Computer®, Inc. proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer program.
May 22, 2024
·
3 min read
Press Releases
CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines
December 10, 2024
·
4 min read
Business
Accumulus Synergy Appoints Jacques Mascaro as Chair of the Board
Accumulus Synergy, a nonprofit trade association working to address the global need for digital transformation within the life sciences - regulatory ecosystem, announced the appointment of Jacques Mascaro as the new Chair of the Board of Directors.
June 22, 2023
·
3 min read
Genetown
Phio Pharmaceuticals Presents Preclinical Data Demonstrating Synergy-Enhanced in vivo Anti-Tumor Efficacy of PD-1/CTLA-4 Dual-Targeting INTASYL
Phio Pharmaceuticals Corp. today announced that in vivo data from a mouse model of colon cancer demonstrates target synergy-enhanced anti-tumor efficacy from a novel dual-targeting mouse PD-1 and CTLA-4 of an INTASYL coformulation.
April 18, 2023
·
4 min read
Genetown
Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced that Synergy Oncology, part of Synergy Laboratories, a full-service diagnostic laboratory based in Mobile, Alabama, will use SOPHiA DDM™ to develop a new cancer profiling solution.
February 28, 2023
·
5 min read
Press Releases
Silexion Therapeutics Announces Additional Promising Preclinical Data for SIL-204, Demonstrating Impressive Synergy with First-Line Pancreatic Cancer Chemotherapies
January 16, 2025
·
5 min read
Press Releases
PESG Market Update: Silexion Therapeutics’ SIL-204 Shows Groundbreaking Synergy in Preclinical Data, Boosting Hope for KRAS-Driven Cancer Treatments
January 17, 2025
·
2 min read
1 of 1,364
Next
